Completed PHASE4 INTERVENTIONAL 2-arm NCT05718544

Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes

Effect of Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia on Long-term Outcomes Following Scoliosis Correction Surgery: 2-year Follow-up of a Randomized Controlled Trial

Sponsor: Peking University First Hospital

Conditions Chronic Postsurgical Pain Dexmedetomidine Esketamine Postoperative Analgesia Scoliosis Correction

Interventions Dexmedetomidine Esketamine Sufentanil

Updated 5 times since 2023 Last updated: Jul 29, 2025 Started: Jan 30, 2023 Primary completion: Sep 7, 2023 Completion: Sep 7, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Chronic Postsurgical Pain and Dexmedetomidine, this trial is completed. The trial is conducted by Peking University First Hospital and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Aug 2025 — Present [monthly]

Completed PHASE4

Status: Unknown → Completed
Mar 2025 — Aug 2025 [monthly]

Unknown PHASE4

Status: Active Not Recruiting → Unknown
Sep 2024 — Mar 2025 [monthly]

Active Not Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE4
Mar 2023 — Jul 2024 [monthly]

Active Not Recruiting PHASE4

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking University First Hospital

Data source: Peking University First Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China